Ortoma AB (publ) (STO: ORT.B)

Market Cap	344.14M
Revenue (ttm)	63.86M
Net Income (ttm)	-29.81M
Shares Out	37.08M
EPS (ttm)	-0.79
PE Ratio	n/a
Forward PE	18.56
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,387
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	6.90 - 13.95
Beta	0.73
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 19, 2025

About Ortoma AB

Ortoma AB (publ) provides orthopedic surgical products for use in joint implant surgery in Sweden. It offers Ortoma Treatment Solution (OTS) that is designed to support various orthopedic joint or spine surgeries in the areas of hip, spine, knee, and shoulders and extremities surgeries; OTS Plan, a software that processes and assists surgeons during pre-operative planning and post-operative follow-up; OTS Guide, an intra-operative navigation tool guiding surgeons to place the implant in the pre-operatively planned position; and OTS Follow up th...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2001
• Employees: 7
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ORT.B

Financial Performance

In 2023, Ortoma AB's revenue was 62.01 million, an increase of 165.31% compared to the previous year's 23.37 million. Losses were -21.87 million, 38.9% more than in 2022.